[Functional vascular acrosyndromes]. 2022

Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
Klinik für Angiologie, Klinikum Ernst von Bergmann, Charlottenstr. 72, 14467, Potsdam, Deutschland. peter.klein-weigel@klinikumevb.de.

Vascular acrosyndromes are characterized by sparse, uniform clinical manifestations and a variety of possible pathomechanisms. The present article focuses on the functional entities. Raynaud phenomenon is based on cold- or stress-induced vasospasms of acral arteries. It is defined by the color changes of the skin, in the typical case white-blue-red (tricolore). The long fingers are most commonly affected. The etiology is unknown, and the pathophysiology is poorly understood. A distinction is made between primary and a secondary Raynaud phenomenon. The most important underlying diseases include collagenosis, primarily systemic sclerosis, and malignancies; furthermore, medications and drugs may promote vasospasm. Treatment is aimed at preventing or breaking the vasospasm, but has been only partially effective in doing so. Acrocyanosis is a vasospastic dystonic acral disorder that results in permanent reddish-livid discoloration, especially of the hands and feet. Secondary forms occur in collagenosis, malignancies, and myelodysplastic syndromes. The etiology and pathophysiology are virtually unknown. Targeted pharmacological intervention is not possible. Unlike all other vascular acrosyndromes, erythromelalgia is characterized by hyperemia. The primary form is a genetic sodium channelopathy, while secondary forms include malignancies, connective tissue diseases, and myelodysplastic syndromes. The symptoms are often distressing and disabling. Therapy requires a multimodal approach that includes both nonpharmacological and pharmacological strategies. Close interdisciplinary collaboration is essential for the management of this disease.

UI MeSH Term Description Entries
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D003490 Cyanosis A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule. Cyanoses
D004916 Erythromelalgia A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS. Erythermalgia,Erythermalgia, Primary,Erythromelalgia, Familial,Erythromelalgia, Primary,Familial Erythromelalgia,Primary Erythermalgia,Primary Erythromelalgia,Erythermalgias,Erythermalgias, Primary,Erythromelalgias,Primary Erythermalgias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
March 1968, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
November 1984, L'Infirmiere francaise,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
April 1990, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
October 1998, La Revue du praticien,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
January 2015, Annales de dermatologie et de venereologie,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
December 1999, Journal des maladies vasculaires,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
April 1986, Soins. Cardiologie,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
November 1973, La Revue du praticien,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
October 1998, La Revue du praticien,
Peter Klein-Weigel, and Andreas Ruttloff, and Dana König, and Jessica Nielitz, and Julia Steindl, and Oliver Sander, and Jutta G Richter
January 1987, Phlebologie,
Copied contents to your clipboard!